BBIO

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

BridgeBio Pharma (BBIO) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

BBIO is expected to report earnings to rise 29.07% to -111 cents per share on February 20

BridgeBio Pharma BBIO Stock Earnings Reports

Q4'24

Est.

$-1.11

Q3'24

Beat

by $0.13

Q2'24

Beat

by $0.41

Q1'24

Beat

by $0.72

Q4'23

Missed

by $0.09

The last earnings report on November 12 showed earnings per share of -86 cents, beating the estimate of -99 cents. With 1.53M shares outstanding, the current market capitalization sits at 5.26B.

View a ticker or compare two or three

Compare

BBIO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For BBIO
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for BBIO (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a company which engages in developing transformative medicines to treat patients who suffer from mendelian diseases.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

3160 Porter Drive

Phone

+1 650 391-9740

Employees

556

Web

https://www.bridgebio.com